Published in Circ Cardiovasc Genet on April 01, 2009
Update 2011: clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol (2011) 2.02
Evaluating pathogenicity of rare variants from dilated cardiomyopathy in the exome era. Circ Cardiovasc Genet (2012) 1.78
Genetic testing for dilated cardiomyopathy in clinical practice. J Card Fail (2012) 1.32
Genetic testing in cardiovascular diseases. Curr Opin Cardiol (2014) 0.88
Future translational applications from the contemporary genomics era: a scientific statement from the American Heart Association. Circulation (2015) 0.81
Return of genetic results in the familial dilated cardiomyopathy research project. J Genet Couns (2012) 0.81
Utility of Genetic Testing in Long QT Syndrome. Circulation (2010) 0.75
Using genetic testing to guide therapeutic decisions in cardiomyopathy. Curr Treat Options Cardiovasc Med (2013) 0.75
Mendelian forms of structural cardiovascular disease. Curr Cardiol Rep (2013) 0.75
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature (2007) 75.09
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med (2004) 71.08
Next-generation DNA sequencing. Nat Biotechnol (2008) 34.95
Genetic mapping in human disease. Science (2008) 15.12
Drug-induced prolongation of the QT interval. N Engl J Med (2004) 10.96
Association study designs for complex diseases. Nat Rev Genet (2001) 8.91
Genome-wide association studies: potential next steps on a genetic journey. Hum Mol Genet (2008) 7.54
A single gene network accurately predicts phenotypic effects of gene perturbation in Caenorhabditis elegans. Nat Genet (2008) 3.62
A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am J Hum Genet (2008) 3.25
Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proc Natl Acad Sci U S A (2008) 2.87
Integrating interactome, phenome, and transcriptome mapping data for the C. elegans germline. Curr Biol (2002) 2.47
A common nonsense mutation results in alpha-actinin-3 deficiency in the general population. Nat Genet (1999) 2.27
A probabilistic view of gene function. Nat Genet (2004) 1.99
Phenotypic diversity in hypertrophic cardiomyopathy. Hum Mol Genet (2002) 1.93
Psychiatric genetics: search for phenotypes. Trends Neurosci (1998) 1.68
Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations. Trends Cardiovasc Med (2008) 1.68
Multiple mutations in genetic cardiovascular disease: a marker of disease severity? Circ Cardiovasc Genet (2009) 1.18
Targeted point mutagenesis of mouse Kcnq1: phenotypic analysis of mice with point mutations that cause Romano-Ward syndrome in humans. Genomics (2004) 1.09
Trait components provide tools to dissect the genetic susceptibility of migraine. Am J Hum Genet (2006) 1.07
Ion channel mutations in AF: signal or noise? Heart Rhythm (2008) 0.99
"Phenome" project set to pin down subgroups of autism. Nat Med (2005) 0.95
Defective ion channel function in the long QT syndrome: multiple unexpected mechanisms. J Mol Cell Cardiol (2001) 0.80
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet (2009) 12.19
Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature (2007) 8.03
Truncations of titin causing dilated cardiomyopathy. N Engl J Med (2012) 6.07
Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet (2010) 3.97
Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet (2004) 3.88
C/EBPβ controls exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell (2010) 2.68
High-throughput assay for small molecules that modulate zebrafish embryonic heart rate. Nat Chem Biol (2005) 2.64
Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation. Nat Biotechnol (2004) 2.57
Familial aggregation in lone atrial fibrillation. Hum Genet (2005) 2.55
Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation (2003) 2.42
Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. J Am Coll Cardiol (2006) 2.29
Locus for atrial fibrillation maps to chromosome 6q14-16. Circulation (2003) 2.28
Klf2 is an essential regulator of vascular hemodynamic forces in vivo. Dev Cell (2006) 2.26
Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. J Am Coll Cardiol (2010) 2.17
Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation. Eur Heart J (2009) 2.06
Notch1b and neuregulin are required for specification of central cardiac conduction tissue. Development (2006) 2.00
RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. Nat Med (2012) 1.97
Pattern recognition: combining informatics and genetics to re-evaluate conduction disease. Heart (2012) 1.91
Fine mapping of the 1p36 deletion syndrome identifies mutation of PRDM16 as a cause of cardiomyopathy. Am J Hum Genet (2013) 1.87
Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy. Heart Rhythm (2011) 1.85
Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease. Ann Intern Med (2005) 1.85
Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy. J Am Coll Cardiol (2010) 1.83
Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations. J Am Coll Cardiol (2010) 1.80
In vivo recording of adult zebrafish electrocardiogram and assessment of drug-induced QT prolongation. Am J Physiol Heart Circ Physiol (2006) 1.77
Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy. JAMA (2009) 1.75
Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet (2006) 1.68
C-Reactive protein in lone atrial fibrillation. Am J Cardiol (2006) 1.68
Cardiac sodium channel gene variants and sudden cardiac death in women. Circulation (2007) 1.67
Gene mutations in apical hypertrophic cardiomyopathy. Circulation (2005) 1.64
The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine. Trials (2014) 1.62
Closer look at genetic testing in long-QT syndrome: will DNA diagnostics ever be enough? Circulation (2009) 1.56
ACE I/D polymorphism associated with abnormal atrial and atrioventricular conduction in lone atrial fibrillation and structural heart disease: implications for electrical remodeling. Heart Rhythm (2009) 1.55
Cardiac sodium channel mutation in atrial fibrillation. Heart Rhythm (2007) 1.50
Arterial tortuosity syndrome with multiple intracranial aneurysms: a case report. Arch Neurol (2011) 1.49
Handheld echocardiography offers rapid assessment of clinical volume status. Am Heart J (2008) 1.49
Integrin-linked kinase regulates endothelial cell survival and vascular development. Mol Cell Biol (2004) 1.46
Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations. Circ Res (2013) 1.44
Drug-sensitized zebrafish screen identifies multiple genes, including GINS3, as regulators of myocardial repolarization. Circulation (2009) 1.41
Human-zebrafish non-coding conserved elements act in vivo to regulate transcription. Nucleic Acids Res (2005) 1.39
Genetic testing for dilated cardiomyopathy in clinical practice. J Card Fail (2012) 1.32
Genetics and cardiovascular disease: a policy statement from the American Heart Association. Circulation (2012) 1.26
Common variants in cardiac ion channel genes are associated with sudden cardiac death. Circ Arrhythm Electrophysiol (2010) 1.22
Potassium channel gene mutations rarely cause atrial fibrillation. BMC Med Genet (2006) 1.21
A novel custom resequencing array for dilated cardiomyopathy. Genet Med (2010) 1.18
A systematic approach to the reporting of medically relevant findings from whole genome sequencing. BMC Med Genet (2014) 1.14
High-resolution cardiovascular function confirms functional orthology of myocardial contractility pathways in zebrafish. Physiol Genomics (2010) 1.10
Notch signaling regulates cardiomyocyte proliferation during zebrafish heart regeneration. Proc Natl Acad Sci U S A (2014) 1.10
Purification of hearts from zebrafish embryos. Biotechniques (2006) 1.07
Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish. Am J Physiol Heart Circ Physiol (2013) 1.06
Animal models for arrhythmias. Cardiovasc Res (2005) 1.05
Human cardiomyopathy mutations induce myocyte hyperplasia and activate hypertrophic pathways during cardiogenesis in zebrafish. Dis Model Mech (2011) 1.03
Subtle abnormalities in contractile function are an early manifestation of sarcomere mutations in dilated cardiomyopathy. Circ Cardiovasc Genet (2012) 1.02
Carotid intima-media thickness is associated with premature parental coronary heart disease: the Framingham Heart Study. Circulation (2003) 1.02
In vivo natriuretic peptide reporter assay identifies chemical modifiers of hypertrophic cardiomyopathy signalling. Cardiovasc Res (2011) 1.01
Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy. Am J Cardiol (2011) 0.99
Ion channel mutations in AF: signal or noise? Heart Rhythm (2008) 0.99
Aging syndrome genes and premature coronary artery disease. BMC Med Genet (2005) 0.95
Techniques for the in vivo assessment of cardio-renal function in zebrafish (Danio rerio) larvae. J Physiol (2012) 0.94
A novel locus for dilated cardiomyopathy, diffuse myocardial fibrosis, and sudden death on chromosome 10q25-26. J Am Coll Cardiol (2006) 0.92
A one-page summary report of genome sequencing for the healthy adult. Public Health Genomics (2015) 0.92
Hedgehog signaling via angiopoietin1 is required for developmental vascular stability. Mech Dev (2010) 0.91
Arrhythmogenic right ventricular cardiomyopathy. Heart Fail Clin (2010) 0.89
Short communication: the cardiac myosin binding protein C Arg502Trp mutation: a common cause of hypertrophic cardiomyopathy. Circ Res (2010) 0.88
Genetic testing in cardiovascular diseases. Curr Opin Cardiol (2014) 0.88
Novel locus for an inherited cardiomyopathy maps to chromosome 7. Circulation (2006) 0.88
Next-generation genome-wide association studies: time to focus on phenotype? Circ Cardiovasc Genet (2011) 0.88
Genetics of atrial fibrillation. Med Clin North Am (2008) 0.88
The genetics of atrial fibrillation. Curr Opin Cardiol (2010) 0.87
Adrenergic-receptor polymorphisms and heart failure. N Engl J Med (2002) 0.87
Myocardial blood flow and oxygen consumption in patients with Friedreich's ataxia prior to the onset of cardiomyopathy. Coron Artery Dis (2007) 0.86
Chemical and metabolomic screens identify novel biomarkers and antidotes for cyanide exposure. FASEB J (2013) 0.86
The zebrafish: scalable in vivo modeling for systems biology. Wiley Interdiscip Rev Syst Biol Med (2010) 0.85
Eya4 regulation of Na+/K+-ATPase is required for sensory system development in zebrafish. Development (2008) 0.85
Genetic testing for inherited heart disease. Circulation (2013) 0.85
Differential activation of natriuretic peptide receptors modulates cardiomyocyte proliferation during development. Development (2013) 0.84
Novel cardiovascular gene functions revealed via systematic phenotype prediction in zebrafish. Development (2014) 0.84
Acquisition, Analysis, and Sharing of Data in 2015 and Beyond: A Survey of the Landscape: A Conference Report From the American Heart Association Data Summit 2015. J Am Heart Assoc (2015) 0.84
Muscle dysfunction in hypertrophic cardiomyopathy: what is needed to move to translation? J Muscle Res Cell Motil (2014) 0.82
Prioritizing causal disease genes using unbiased genomic features. Genome Biol (2014) 0.82
Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy. Circ Cardiovasc Genet (2013) 0.81
Future translational applications from the contemporary genomics era: a scientific statement from the American Heart Association. Circulation (2015) 0.81
Hypertrophic cardiomyopathy without hypertrophy: an emerging pre-clinical subgroup composed of genetically affected family members. JACC Cardiovasc Imaging (2009) 0.81
New Paradigms in Hypertrophic Cardiomyopathy: Insights from Genetics. Prog Pediatr Cardiol (2011) 0.80
Cardiovascular manifestations of Fabry disease: relationships between left ventricular hypertrophy, disease severity, and alpha-galactosidase A activity. Eur Heart J (2010) 0.80
CORRIGENDUM: Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity. Genet Med (2015) 0.79
Action and the actionability in exome variation. Circ Cardiovasc Genet (2012) 0.79
A clinical approach to inherited hypertrophy: the use of family history in diagnosis, risk assessment, and management. Circ Cardiovasc Genet (2013) 0.79
Genetic testing in cardiac disease: from bench to bedside. Nat Clin Pract Cardiovasc Med (2006) 0.78
Symptoms in atrial fibrillation: why keep score? Circ Arrhythm Electrophysiol (2009) 0.78
Growth arrest specific gene (GAS) 6 modulates platelet thrombus formation and vascular wall homeostasis and represents an attractive drug target. Curr Pharm Des (2007) 0.78
Clinical screening and genetic testing. Clin Lab Med (2010) 0.77
Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity. EMBO Mol Med (2015) 0.76
Genetic screening and risk assessment in hypertrophic cardiomyopathy. J Am Coll Cardiol (2004) 0.76
Sequential effects of spadetail, one-eyed pinhead and no tail on midline convergence of nephric primordia during zebrafish embryogenesis. Dev Biol (2013) 0.76
Profound left ventricular remodeling associated with LAMP2 cardiomyopathy. Am J Cardiol (2010) 0.76
Risk stratification in the long-QT syndrome. N Engl J Med (2003) 0.75
Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function. J Clin Invest (2017) 0.75
Clinical screening and genetic testing. Heart Fail Clin (2010) 0.75